These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 13729079)

  • 21. [On the problem of the method of determination of properdin in human serum by the zymosan method].
    MASHKOV AV; MIKHAILOVA ZM
    Zh Mikrobiol Epidemiol Immunobiol; 1962 May; 33():103-8. PubMed ID: 14470783
    [No Abstract]   [Full Text] [Related]  

  • 22. The properdin system and immunity. VII. Alterations in properdin levels and resistance to infection in mice following the administration of tissue polysaccharides.
    PILLEMER L; LANDY M; SHEAR MJ
    J Exp Med; 1957 Jul; 106(1):99-110. PubMed ID: 13439118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [On the possibility of determination of blood properdin by means of zymosan in the serums of different animal species].
    MAZZEI D; TASCHINI P
    Policlinico Med; 1959; 66():391-401. PubMed ID: 13853881
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of properdin titers in sera of normal subjects and patients with leukemia and lymphoma by zymosan and bacteriophage assavs.
    BALTCH AL; HASSIRDJIAN A; OSBORNE W; BUNN PA
    J Lab Clin Med; 1961 Mar; 57():420-7. PubMed ID: 13686461
    [No Abstract]   [Full Text] [Related]  

  • 25. [The usefulness of various zymosan preparations in determination of properdin].
    von GRAEVENITZ ; HUSMANN KH; HOEBBEL K
    Med Exp Int J Exp Med; 1960; 3():230-6. PubMed ID: 13707673
    [No Abstract]   [Full Text] [Related]  

  • 26. [Mouse protection studies with zymosan vaccines and properdin sera. Contribution to unspecified immunity (resistance)].
    ZIMMERMANN G
    Acta Biol Med Ger; 1962; 9():412-27. PubMed ID: 14003718
    [No Abstract]   [Full Text] [Related]  

  • 27. [THE ROLE OF THE PROPERDIN SYSTEM IN NON-SPECIFIC IMMUNITY].
    HOSHINO A
    Nihon Naika Gakkai Zasshi; 1963 Dec; 52():1023-40. PubMed ID: 14158037
    [No Abstract]   [Full Text] [Related]  

  • 28. [NATURAL INNATE IMMUNITY FOR BRUCELLA MELITENSIS. I. RELATION WITH PROPERDIN, COMPLEMENT, BACTERICIDAL PROPERTIES OF SERUM AND THE FORMATION OF SPECIFIC ANTIBODIES].
    LEON AP; OSOLLO G; CANO C
    Rev Inst Salubr Enferm Trop; 1962 Dec; 22():145-72. PubMed ID: 14076958
    [No Abstract]   [Full Text] [Related]  

  • 29. Quantitative studies of the properdin-complement system. III. Kinetics of the reaction between C'3 and the properdin-zymosan complex.
    LEON MA
    J Immunol; 1958 Jul; 81(1):23-8. PubMed ID: 13563875
    [No Abstract]   [Full Text] [Related]  

  • 30. [OBSERVATION ON TUMORAL IMMUNITY IN CONNECTION WITH THE PROPERDIN SYSTEM].
    NAGY IS; ATS M; KOSZORU M; LUST I
    Sangre (Barc); 1964; 17():272-4. PubMed ID: 14218362
    [No Abstract]   [Full Text] [Related]  

  • 31. Properdin system and immunity. II. Interaction of the properdin system with polysaccharides.
    PILLEMER L; SCHOENBERG MD; BLUM L; WURZ L
    Science; 1955 Sep; 122(3169):545-9. PubMed ID: 13255887
    [No Abstract]   [Full Text] [Related]  

  • 32. The rabbit properdin system: I. Identification of a new factor and purification of rabbit properdin.
    Naff GB; Hedrick SW; Ratnoff WD; Novak MA; Smith MC; Steiner C; Todd EW
    J Immunol; 1980 Jun; 124(6):2625-31. PubMed ID: 6900053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the mechanism of properdin--zymosan reaction. The role of polysaccharide structure in combination with properdin.
    CSEH G; SZABO I
    Acta Microbiol Acad Sci Hung; 1961; 8():181-7. PubMed ID: 13718704
    [No Abstract]   [Full Text] [Related]  

  • 34. [Bactericidal activity of normal and low-properdin sera and of properdin-zymosan complexes].
    SZEMERE G
    Kiserl Orvostud; 1963 Feb; 15():58-61. PubMed ID: 13979914
    [No Abstract]   [Full Text] [Related]  

  • 35. Properdin deficiency in murine models of nonseptic shock.
    Ivanovska ND; Dimitrova PA; Luckett JC; El-Rachkidy Lonnen R; Schwaeble WJ; Stover CM
    J Immunol; 2008 May; 180(10):6962-9. PubMed ID: 18453618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An alternative mechanism for the properdin system.
    NELSON RA
    J Exp Med; 1958 Oct; 108(4):515-35. PubMed ID: 13575682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Replacement of magnesium by cobalt and manganese in the interactions of the properdin system with bacteria and with zymosan.
    WARDLAW AC; BLUM L; PILLEMER L
    J Immunol; 1958 Jul; 81(1):43-7. PubMed ID: 13563878
    [No Abstract]   [Full Text] [Related]  

  • 38. [Validity and limitations in the determination of serum properdin by means of zymosan].
    ZANUSSI C; TASCHINI P; SELVA G; ORTOLANI C
    Boll Ist Sieroter Milan; 1958; 37(5-6):237-45. PubMed ID: 13560652
    [No Abstract]   [Full Text] [Related]  

  • 39. [Immuno-electrophoretic studies on properdin-zymosan and properdin-inulin complex; an analysis of electrophoretic and immunologic behavior of properdin].
    SCHEIFFARTH F; FRENGER W; GOTZ H
    Klin Wochenschr; 1958 Apr; 36(8):367-9. PubMed ID: 13550834
    [No Abstract]   [Full Text] [Related]  

  • 40. [ULTRACENTRIFUGE STUDIES ON PROPERDIN SERA OF ZYMOSAN-VACCINATED CATTLE, RABBITS, GUINEA PIGS, RATS AND MICE AND ON BOVINE PROPERDIN SERUM FRACTIONS].
    ZIMMERMANN G; KRUEGER K
    Acta Biol Med Ger; 1963; 11():902-17. PubMed ID: 14121884
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.